Othman Al-Sawaf, MD on Venetoclax-Obinutuzumab For Untreated Patients with CLL

Othman Al-Sawaf, MD on Venetoclax-Obinutuzumab For Untreated Patients with CLL

User Photo
Cancer-News

1 month
29 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 1
Category:
Description:

Othman Al-Sawaf, MD of University Hospital Cologne discusses fixed-duration venetoclax-obinutuzumab forpreviously untreated patients with CLL: follow-up of efficacy and safety results from the multicenter, open-label, randomized, phase III CLL14 trial.

Read here: https://meetinglibrary.asco.org/record/186845/abstract

Up Next Autoplay
User Photo